Authors
Loading...
Supports gap junction remodeling in ischemic/hypertrophic hearts as potential arrhythmogenic substrate; leaves open whether connexin-targeted therapies improve outcomes.
Key points are not available for this paper at this time.
Nicholas S. Peters (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: